TP53 and hepatocellular carcinoma: MTS assay was performed to measure the cellular viability at 72 h for four p53 mutated HCC cell lines (Huh7, HLF, HLE, PLC/PRF5), one p53 null cell line (Hep3B) and two wild-type p53 HCC cell lines (HepG2 and THH).